ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugKalVista Pharmaceuticals Switzerland GmbH
KalVista Pharmaceuticals Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

KalVista Pharmaceuticals Switzerland GmbH is a biopharmaceutical company that develops and delivers oral therapies for rare diseases. Its work focuses on hereditary angioedema (HAE) and on research programs for oral Factor XIIa inhibitors and other disease areas.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

KalVista Pharmaceuticals Switzerland GmbH

✓ Offered4
Development of medicines for hereditary angioedema (HAE)
Development of orally administered small-molecule medicines for hereditary angioedema, focused on new treatment options and the needs of HAE patients.
Research and pipeline development
Research, scientific development and pipeline work for medicines, starting with HAE and an oral Factor-XIIa inhibitor.
Information for patients and caregivers
Patient information on HAE, treatment options, and disease-related background information for patients and caregivers.
Information for healthcare professionals
Specialist information for healthcare professionals on HAE, scientific background and treatment-related content.
Trust & reputation

ranQ Trust Score of KalVista Pharmaceuticals Switzerland GmbH: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

KalVista Pharmaceuticals Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
KalVista Pharmaceuticals Switzerland GmbH scores 57.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
KalVista Pharmaceuticals Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
KalVista Pharmaceuticals Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

KalVista Pharmaceuticals Switzerland GmbH reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once KalVista Pharmaceuticals Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

KalVista Pharmaceuticals Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank KalVista Pharmaceuticals Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of KalVista Pharmaceuticals Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 135
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-476.260.624
Founded
2024 · 2 years
Last commercial register change
August 5, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    JA
    Janssen-Cilag AG
    Zug
    OT
    Orchard Therapeutics (Switzerland) GmbH
    Zug
    TP
    Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
    Zug
    DP
    Deciphera Pharmaceuticals (Schweiz) AG
    Zug
    BI
    BridgeBio International GmbH
    Zug
    IP
    IPSEN Pharma Schweiz GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    OS
    ORACTIVE SWISS AG
    Zug